Surgical vs. Medical Management of Infective Endocarditis Following TAVR: A Systematic Review and Meta-Analysis
Why the study?
The optimal treatment strategy between surgical explantation and medical therapy for infective endocarditis following TAVR remains uncertain.
Does surgical management improve survival compared to medical therapy in patients with infective endocarditis following TAVR?
Population
Patients with infective endocarditis after TAVR
Comparison
Surgical explantation vs medical therapy
Design
Systematic review and meta-analysis
Follow-up
1-year
Authors
Discussion
Loading...
Member takes
Implication
May support surgical explantation in selected TAVR-IE patients at high-volume centers; leaves open need for prospective confirmation.
Structured PICO
Does surgical management improve survival compared to medical therapy in patients with infective endocarditis following TAVR?
P
Population
Patients with infective endocarditis after transcatheter aortic valve replacement (TAVR-IE)
I
Intervention
Surgical management (surgical explantation)
C
Comparator
Medical management (medical therapy)
O
Outcome
30-day mortality and 1-year survivalhard clinical
Surgical explantation for TAVR-IE may offer significant survival benefits over medical therapy in appropriately selected patients, particularly when performed at high-volume centers.
Cite This Study
Magouliotis et al. (2025) studied this question.